TC Medical(SH:600763) Sou Hu Cai Jing·2026-02-03 11:57Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Tongce Medical (600763), indicating a positive trend in both stock price and financial results [1][2] - As of February 3, 2026, Tongce Medical's stock closed at 48.26 yuan, reflecting a 2.25% increase with a trading volume of 170,400 hands and a total transaction amount of 818 million yuan [1] - In terms of capital flow on February 3, 2026, the net inflow of main funds was 44.53 million yuan, accounting for 5.44% of the total transaction amount, while retail investors experienced a net outflow of 2.59 million yuan, representing 0.32% of the total [1] Group 2 - For the first three quarters of 2025, Tongce Medical reported a main revenue of 2.29 billion yuan, a year-on-year increase of 2.56%, and a net profit attributable to shareholders of 514 million yuan, up 3.16% year-on-year [2] - The third quarter of 2025 saw a single-quarter main revenue of 842 million yuan, reflecting a 2.34% year-on-year increase, with a net profit of 192 million yuan, up 2.31% year-on-year [2] - The company has a debt ratio of 25.1%, with investment income of 41.22 million yuan and financial expenses of 31.93 million yuan, alongside a gross profit margin of 41.69% [2] Group 3 - Over the past 90 days, five institutions have provided ratings for Tongce Medical, with three giving a "buy" rating and two an "increase" rating, while the average target price set by institutions is 51.1 yuan [2]